SCHEMBL15879481

SCHEMBL15879481

O=S(=O)(Cl)c1ccc2cccccc1-2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.48
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP2A6 P11509 1/20 0.43
PTGS1 P23219 2/20 0.40
AKR1B1 P15121 1/20 0.40
MEN1 O00255 1/20 0.39
APAF1 O14727 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
XBP1 P17861 1/20 0.39
PTBP1 P26599 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
GALK1 P51570 1/20 0.39
BLM P54132 1/20 0.39
SMAD3 P84022 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL313390 0.93 ALDH1A1 (0.46) PTGS2ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL31194215 0.83 PTGS2 (0.46) PTGS2ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL4202592 0.83 PTGS2 (0.55) PTGS2ALDH1A1PTGS1MAPTRAB9A
SCHEMBL8196670 0.83 ALDH1A1 (0.61) PTGS2ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL5711493 0.82 PTGS2 (0.52) PTGS2ALDH1A1HSD17B10CYP2A6PTGS1
SCHEMBL2007711 0.82 PTPRC (0.44) PTGS2ALDH1A1HSD17B10TDP1PTGS1
SCHEMBL5682823 0.82 CA12 (0.42) PTGS2ALDH1A1HSD17B10TDP1MEN1
SCHEMBL2008147 0.82 PTGS2 (0.53) PTGS2ALDH1A1PTGS1MEN1NPC1
SCHEMBL17628496 0.82 ALDH1A1 (0.40) PTGS2ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL27691428 0.80 ALDH1A1 (0.48) PTGS2ALDH1A1HSD17B10TDP1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376382-B2 N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof SICHUAN GUOKANG PHARMACEUTICAL CO., LTD. (CN) 2016-06-28 US claimed
US-20140206741-A1 N-SUBSTITUTED ISOPROPYLDIMETHYL AZULENE SULFONAMIDE DERIVATIVES, AND PREPARATION METHOD AND USE THEREOF SICHUAN GUOKANG PHARMACEUTICAL CO., LTD (CN) 2014-07-24 US claimed
CN-119528772-A Preparation method of azulene sulfonamide 山东华素制药有限公司 2025-02-28 CN disclosed
CN-119528772-A Preparation method of azulene sulfonamide 山东华素制药有限公司 2025-02-28 CN disclosed
US-9376382-B2 N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof SICHUAN GUOKANG PHARMACEUTICAL CO., LTD. (CN) 2016-06-28 US disclosed
US-20140206741-A1 N-SUBSTITUTED ISOPROPYLDIMETHYL AZULENE SULFONAMIDE DERIVATIVES, AND PREPARATION METHOD AND USE THEREOF SICHUAN GUOKANG PHARMACEUTICAL CO., LTD (CN) 2014-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140206741-A1 N-SUBSTITUTED ISOPROPYLDIMETHYL AZULENE SULFONAMIDE DERIVATIVES, AND PREPARATION METHOD AND USE THEREOF GIPR, SSTR5, STS PTGS2 382/4885ALDH1A1 244/4885HSD17B10 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.